BiotechTube
Home/Synklino/Jette Wagtberg Sen
JW

Jette Wagtberg Sen

COO

Synklino

Therapeutic Areas

Infectious DiseasesTransplantation

Synklino Pipeline

DrugIndicationPhase
SYN002Prevention of Cytomegalovirus (CMV) infection in transplant recipientsPre-clinical

Leadership Team at Synklino

TK
Thomas Kledal
CEO & Co-founder
View full Synklino profile